Clinical Trial Update: Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the bupivacaine patch Eladur for postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Eladur (bupivacaine)

Snippet

Sponsor: Durect | Conditions: Postherpetic Neuralgia, Pain | Phase 2 | Status: COMPLETED